Beijing Tong Ren Tang Chinese Medicine Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Beijing Tong Ren Tang Chinese Medicine heeft een totaal eigen vermogen van HK$4.0B en een totale schuld van HK$249.0K, wat de schuld-eigenvermogensverhouding op 0.01% brengt. De totale activa en totale passiva bedragen respectievelijk HK$4.3B en HK$308.3M. De EBIT Beijing Tong Ren Tang Chinese Medicine is HK$551.1M waardoor de rentedekking -7.6 is. Het heeft contanten en kortetermijnbeleggingen van HK$1.8B.
Belangrijke informatie
0.006%
Verhouding schuld/eigen vermogen
HK$249.00k
Schuld
| Rente dekkingsratio | -7.6x |
| Contant | HK$1.79b |
| Aandelen | HK$3.97b |
| Totaal verplichtingen | HK$308.26m |
| Totaal activa | HK$4.28b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up
Oct 04
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders
Sep 06Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?
Sep 02Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk
Feb 05Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Jan 03A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Sep 28Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today
Jul 12Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?
Mar 29Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28
Apr 28Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28
Mar 25Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?
Oct 27Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 28Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Mar 11What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 04Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?
Jan 18
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?
Dec 29Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Dec 11Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 23Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( HK$3.7B ) 3613 } overtreffen de korte termijn passiva ( HK$221.1M ).
Langlopende schulden: De kortetermijnactiva 3613 ( HK$3.7B ) overtreffen de langetermijnschulden ( HK$87.2M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 3613 heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van 3613 is de afgelopen 5 jaar gedaald van 0.04% naar 0.01%.
Schuldendekking: De operationele kasstroom van 3613 is negatief, waardoor de schuld niet goed gedekt is.
Rentedekking: 3613 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.